Nexus-6 androids (replicants)
Bioengineered artificial humans, physically and mentally near-indistinguishable from people, manufactured as adults with implanted memories and a built-in four-year lifespan.
In shortNexus-6 androids (replicants), from Do Androids Dream of Electric Sheep? (Philip K. Dick, 1968), is at technology readiness level 2 of 9 (technology concept formulated) at its weakest link. Held back by Synthetic human genome design and assembly, Full-term ectogenesis and Mechanistic theory of neural computation. Science status: consistent with known physics; key effects unproven at scale. Estimated new funding to unlock: $31B–139B (a floor; some parts are priced only to early research).
Rosen Association Nexus-6 androids escape from Mars to Earth, detectable only by the Voigt-Kampff empathy test and bone-marrow analysis.
Closest todaySynthetic genome projects, artificial-womb lamb trials and optogenetic false memories in mice.
Dependency stack
- Designing a complete human-like organism with engineered traits
- Assembly and delivery of megabase DNA into mammalian cells is inefficient
- Cannot predict phenotype from designed sequence for complex traits like strength or intelligence
- Testing designs requires embryos and developmental models
TRL 2- Designing traits requires predicting phenotype from sequence
✕3 blockers›
- Scores tag correlated variants rather than causal ones, so editing the top-ranked variant need not move the trait
- Non-additive effects, pleiotropy and gene-environment interaction are unmodeled
- Ancestry portability is poor because training cohorts are predominantly European
TRL 3 - Precise editing tools underpin incremental genome rewriting and testing
✕2 blockers›
- Delivery to tissues beyond liver
- Long-term off-target safety
TRL 6
- Growing bodies outside a mother, and rapidly to adulthood
- The gap between day-14 embryo culture and artificial-placenta viability covers organogenesis, the hardest and least substitutable phase
- No artificial implantation or placental organ exists to supply hormones and nutrient exchange during that gap
- Scaling implies thousands of parallel units with sterility and uninterrupted power for nine months each
TRL 2- The early half cannot be built without reconstructing implantation and placental exchange
✕3 blockers›
- The placenta's endocrine and nutrient-exchange functions have not been reproduced by any device or culture
- Maternal immune tolerance at the interface is not understood well enough to substitute for
- Human implantation cannot be studied past the 14-day limit, so the critical window is inaccessible
TRL 3 - An engineered placenta is a vascularized tissue that must be grown, not just machined
✕4 blockers›
- Capillary-scale perfusion cannot be printed and must self-assemble, which is uncontrolled today
- Printed tissue must mature into function (filtration, metabolism, contraction), and maturation protocols stall at fetal-like performance
- Cell demand of 10^10-10^11 per organ exceeds current manufacturing
- Mechanical integration - ureters, bile ducts, valves - has no demonstrated fabrication route
TRL 4- Without a capillary network, tissue thicker than a few hundred microns dies
✕3 blockers›
- Printing resolution stops at tens of microns while capillaries are 5-10 microns, so the smallest and most numerous vessels must self-assemble
- Engineered endothelium is thrombogenic, so perfused constructs clot
- No method guides anastomosis of a construct's vasculature to host vessels at scale
TRL 3 - Banked-cell organs are not patient-matched, so acceptance must be engineered
✕3 blockers›
- Chronic antibody-mediated rejection proceeds even under current immunosuppression
- Tolerance protocols trade rejection risk for conditioning toxicity and graft-versus-host disease
- No assay predicts which recipients can be safely weaned off drugs
TRL 5 - One organ needs 10^10-10^11 clinical-grade cells of several types
✕3 blockers›
- Genomic instability and drift accumulate over the expansion needed for 10^11 cells
- Each organ needs many cell types differentiated on a synchronized schedule, not one lineage
- Cost per cell at current media and reagent prices makes a printed organ unaffordable
TRL 6
- Supplies the late-gestation half of the problem
✕4 blockers›
- Miniaturization - the lamb model weighs 1-3 kg while a 23-week human fetus is about 500 g, with shorter umbilical cannulation distances
- Umbilical vessel vasospasm and thrombosis during cannulation and over weeks of support
- Infection control in a continuously exchanged sterile fluid environment
- No agreed proof-of-concept endpoint or animal model that maps onto human neonatal outcomes
TRL 5- Sterile fluid exchange, nutrition and waste handling must run continuously without interruption
✕2 blockers›
- Food production closure
- Microbial and ecological stability over years
TRL 5 - Gas exchange through the umbilical circuit for weeks is the core function
✕3 blockers›
- Blood-surface contact activates coagulation, so runs depend on anticoagulation that causes bleeding in fragile patients
- Oxygenator plasma leakage and fiber fouling limit single-circuit life
- Hemolysis and platelet consumption scale with pump shear and circuit length
TRL 7
- Designing brains with human-level cognition and tuned empathy
- Unknown sufficient level of biological detail
plausibleTRL 2- Wiring diagrams constrain and test circuit models
✕3 blockers›
- Human proofreading of AI segmentation dominates cost; 2025 methods imply tens of billions of dollars for one mouse brain
- Imaging throughput and storage; a human brain at EM resolution is of order 100+ exabytes of raw data
- Sectioning or expanding whole large brains without tissue loss or distortion
TRL 3- Ultrastructure must survive preservation before it can be imaged
✕3 blockers›
- Ischemic damage starts within minutes of circulatory arrest, before perfusion can begin
- Aldehyde fixation may destroy molecular state (phosphorylation, receptor conformation) that could carry memory
- No assay proves preserved tissue still contains the information an emulation would need
TRL 4 - Automated segmentation and tracing of exabyte-scale image volumes
✕2 blockers›
- Grid power and interconnection queues
- Advanced-node chip and HBM memory supply
TRL 8
- Rachael's implanted childhood memories
✕4 blockers›
- Human engrams cannot be labeled; the mouse toolkit depends on transgenic c-fos tagging
- Memory is distributed across an engram complex in many regions, not one addressable site
- Writing content requires knowing the ensemble code for arbitrary experience, which is unknown
- Specificity; stimulation that strengthens one memory also perturbs neighbours
plausibleTRL 3- Writing a memory requires knowing what code represents its contentplausibleTRL 2
- Activity-dependent labeling in humans would need brain-wide gene delivery
✕3 blockers›
- Receptor targeting is species-specific; capsids binding human TfR1 often fail in macaque
- Pre-existing anti-AAV immunity excludes a large fraction of patients and blocks redosing
- Dose needed for brain-wide coverage drives liver toxicity and manufacturing cost
TRL 4- Designed capsid and shuttle proteins are the main route to receptor-specific transcytosis
✕1 blocker›
- Designing catalysis and conformational dynamics
TRL 6
- Engram ensembles must be addressed at single-cell scale in deep structures
✕2 blockers›
- Tissue response degrades signal over years
- Channel count and wireless bandwidth
TRL 6- Channel count is limited by wireless data and power budget
✕3 blockers›
- Tissue heating caps implant power at a few hundred milliwatts, which bounds radio and compute
- Raw broadband neural data exceeds the link, forcing on-implant spike detection and compression
- Battery or wireless-power lifetime versus the decades a permanent interface implies
TRL 5- Implant power density sets what telemetry and on-board compute are affordable
✕2 blockers›
- Cycle life of lithium-metal anodes
- Thermal runaway safety
TRL 6
- supportingSafe heritable embryo genome editingEngineering limited lifespan and enhanced strength into the germline
✕3 blockers›
- Mosaicism - edits arrive after the first division, so cells of the same embryo differ
- On-target large deletions, chromosome loss and chromothripsis occur in edited embryos and are invisible to biopsy-based testing
- A biopsy of a few cells cannot certify the genome of the whole future person, so safety cannot be established before a birth
TRL 3- Editing and screening gametes before fertilization avoids embryo mosaicism altogether
✕3 blockers›
- Human oocyte maturation needs months of follicle growth that culture cannot yet sustain
- Meiotic recombination and chromosome segregation are error-prone outside the ovary, giving aneuploidy
- Imprinting marks are set during germ-cell development and are mis-set in vitro, with no safety assay short of a live birth
TRL 3 - Any multi-trait germline change needs many simultaneous precise edits
✕3 blockers›
- Structural variants and large deletions accumulate with edit count and are missed by short-read screening
- Edited cell lines lose clonogenic and developmental potency after many rounds of editing
- No method reaches the thousands of edits implied by whole-genome rewriting
TRL 6- Higher-fidelity, smaller editor and recombinase proteins are the route to many simultaneous editsTRL 6
Who could unlock it
- Jason ChinResearcher, MRC Laboratory of Molecular Biology and the Generative Biology Institute, Ellison Institute of Technology, OxfordLeads SynHG and previously built synthetic recoded E. coli genomes; his group is developing the assembly tools for megabase-scale human sequence
- SynHG (Synthetic Human Genome Project)ProgramFive-year project launched June 2025 with GBP 10M from Wellcome across Cambridge, Kent, Manchester, Oxford and Imperial, targeting a first synthetic human chromosome (about 2 percent of the genome)
- Patrick Yizhi CaiResearcher, University of ManchesterDesigned synthetic yeast chromosomes for Sc2.0 and is a SynHG co-investigator, bringing the only completed whole-eukaryotic-genome synthesis experience to the human effort
- Ansa BiotechnologiesStartupEnzymatic DNA synthesis using TdT-nucleotide conjugates; now delivers 50 kb clonal DNA in 24 days at $0.28-0.38 per base pair after a $54.4M Series B in October 2025 ($134M total)
- Jacob HannaResearcher, Weizmann Institute of ScienceGrew natural mouse embryos ex utero from E5.5 to E11 through organogenesis (Nature, 2021) and generated transgene-free post-gastrulation whole embryo models from naive stem cells (Cell Stem Cell, 2025); holds an ERC grant titled ExUteroEmbryogenesis
- Alejandro Aguilera-CastrejonResearcher, Janelia Research Campus, HHMIBuilt the roller and perfusion ex utero culture platform in the Hanna lab and now works explicitly toward birthing a mouse from an incubator
- Renewal BioStartupIsraeli company co-founded by Hanna in 2022 that licensed the Weizmann ex utero and synthetic-embryo patents (about $9M raised via NFX) to grow early tissue as a cell source
- Vitara BiomedicalStartupWorking the opposite end of the same problem - fluid-filled support from roughly 22 weeks of human gestation onward, the only part of full-term ectogenesis anywhere near clinical use
- Philip ShiuResearcher, Eon SystemsBuilt the leaky integrate-and-fire whole fly brain model that predicts sensorimotor circuit responses (Nature 2024)
- Srinivas TuragaResearcher, HHMI Janelia Research CampusCo-led connectome-constrained networks that predict neural activity across the fly visual system (Nature 2024)
- Larry AbbottResearcher, Columbia UniversityTheoretical neuroscientist; co-director of the Zuckerman Institute's Center for Theoretical Neuroscience
- Allen InstituteAcademic labMICrONS functional connectomics and a 230,000-cell biophysical model of mouse visual cortex
- Susumu TonegawaResearcher, MIT Picower InstituteHis lab first optogenetically reactivated and implanted false memories in tagged engram cells in mice (2012-2013)
- Sheena JosselynResearcher, SickKids and University of TorontoShowed engram allocation, erasure and artificial memory formation in mice; 2025 Cell paper on stress-inflated engrams
- Steve RamirezResearcher, Boston UniversityEngram manipulation to alleviate maladaptive memory states in mice
- Robert HampsonResearcher, Wake Forest University School of MedicineHippocampal memory-decoding-model stimulation facilitated content-specific recall in epilepsy patients (Front. Comput. Neurosci. 2024)
Beyond engineering
- Creating sentient beings as property is slavery under any human-rights framework
- Human reproductive cloning and germline engineering bans